Whole Exome Sequencing Based Diagnostics in Complex Childhood Epilepsy Syndromes—A Cohort Study on Clinical Utility
Clinical Genetics · 2026
DOI: 10.1111/cge.70061 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Genetics, 2026. Verfasst von Alfiya Fasaludeen und 9 weiteren Autor:innen. Beteiligte Einrichtung: R Madhavan Nayar Centre for Comprehensive Epilepsy Care, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, …. Hauptthemen laut MEDLINE: Exome Sequencing, Epilepsy, Genetic Predisposition to Disease, Epileptic Syndromes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Studies from the subcontinent on the utility of Whole Exome Sequencing (WES) in electro‐clinical phenotypes of childhood‐onset drug‐resistant epilepsy (DRE) syndromes, particularly the developmental and epileptic encephalopathies (DEE), are rare in the literature. Patients with DRE phenotypes of presumed genetic etiology with an age of onset of epilepsy < 12 years, with/without developmental encephalopathy, were included in this study. Our study cohort ( N = 175) included 158 trios, 6 duos, and 11 proband‐only samples. Age at onset of seizures was ≤ 3 years in 76.6% and > 3 years in 23.4%, with developmental delay noted in 80.6% of the cohort. The overall yield of pathogenic/likely pathogenic variants in WES was 38.9% (68/175, 19 were novel); for trio‐WES it was 41.1%. Predominantly de novo variants accounted for 45 out of 68 cases (66.2%), and the most frequent disease‐causing variants were missense (74%). Younger age at onset of epilepsy, female gender and electroclinical diagnosis of Dravet syndrome were associated with a higher yield as opposed to focal epilepsies. Precision medicine was considered tenable in 25/68 (36.8%) cases. Our study reveals a significant yield of trio‐WES for de novo variants in childhood‐onset DRE/DEE. Female gender, early age at onset, and specific electro‐clinical phenotypes have a higher likelihood of identifying a monogenic etiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- R Madhavan Nayar Centre for Comprehensive Epilepsy Care, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
- Human Molecular Genetics Laboratory, Rajiv Gandhi Centre for Biotechnology, Trivandrum, Kerala, India.
- Pediatric Neurology & Neuodevelopmental Disorders, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
- Department of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
- Translational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
- Department of Pediatric Genetics, Amrita Institute of Medical Sciences & Research Centre, Cochin, India.
ORCID-Profile: Madhusoodanan Urulangodi, Dinesh Gupta, Ramshekhar N Menon
Förderung
- Indian Council of Medical Research
Zitieren
APA
Fasaludeen, A., Jose, M., Aswathi, U., Banerjee, M., Sundaram, S., Radhakrishnan, A., Urulangodi, M., Gupta, D., Nampoothiri, S., & Menon, R. N. (2026). Whole Exome Sequencing Based Diagnostics in Complex Childhood Epilepsy Syndromes—A Cohort Study on Clinical Utility. Clinical Genetics. https://doi.org/10.1111/cge.70061
Vancouver
Fasaludeen A, Jose M, Aswathi U, Banerjee M, Sundaram S, Radhakrishnan A, et al. Whole Exome Sequencing Based Diagnostics in Complex Childhood Epilepsy Syndromes—A Cohort Study on Clinical Utility. Clinical Genetics. 2026. doi:10.1111/cge.70061
BibTeX
@article{Fasaludeen2026,
author = {Fasaludeen, Alfiya and Jose, Manna and Aswathi, U and Banerjee, Moinak and Sundaram, Soumya and Radhakrishnan, Ashalatha and Urulangodi, Madhusoodanan and Gupta, Dinesh and Nampoothiri, Sheela and Menon, Ramshekhar N},
title = {Whole Exome Sequencing Based Diagnostics in Complex Childhood Epilepsy Syndromes—A Cohort Study on Clinical Utility},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70061}
}
EUVIMED